EDP Sciences logo
Submit your paper
Search
Menu
All issues Volume 43 / No 4 (December 2011) J Extra Corpor Technol, 43 4 (2011) 195-206 References
Free Access
Review
Issue
J Extra Corpor Technol
Volume 43, Number 4, December 2011
Page(s) 195 - 206
DOI https://doi.org/10.1051/ject/201143195
Published online 15 December 2011
  1. Matsumura KN, Guevara GR, Huston H, et al. Hybrid bioartificial liver in hepatic failure: Preliminary clinical report. Surgery. 1987;101:99–103. [PubMed] [Google Scholar]
  2. Jones RS, ed. Atlas of Liver and Biliary Surgery. Chicago: Year Book Medical Publ.; 1990:307–312. [Google Scholar]
  3. Sasse D. Regulation of hepatic metabolism, intra and intercellular compartmentalization. New York: Plenum; 1986:43–53. [Google Scholar]
  4. Bioulac-Sage P, Le Bail B, Balabaud C. Liver and biliary-tract histology. In: Bircher J, Benhamou JP, McIntyre N, Rizzeto M, Rodes J, eds. Oxford Textbook of Clinical Hepatology. Oxford/New York: Oxford University Press; 1999:13–22. [Google Scholar]
  5. Rappaport AM, Borowy ZJ, Lougheed WM. Subdivision of hexagonal liver lobules into a structural and functional unit. Anat Rec. 1996;199:11–33. [Google Scholar]
  6. Berkowitz CM, Guibert E, Bilir B, Gumucio JJ. Functional compartmentalization of hepatocytes. In: LeBouton AV, ed. Molecular and Cell Biology of the Liver. Oxford/New York: Oxford University Press; 1993;346–367. [Google Scholar]
  7. Leeuw AM, Brouwer A, Knook DL. Sinusoidal endothelial cells of the liver: Fine structure and function in relation to age. J Electron Microsc Tech. 1990;14:218–236. [CrossRef] [PubMed] [Google Scholar]
  8. Gumucio JJ, Chianale J. Liver Cell Heterogeneity and Liver Function. In: Arias IM, Jakoby WB, Popper H, Schachter D, Shafritz DA, eds. The Liver: Biology and Pathobiology. New York: Raven Press; 1988:931–947. [Google Scholar]
  9. Vander AJ. Human Physiology. The Mechanism of Body Function, 7th edition New York: McGraw-Hill; 1999:123–143. [Google Scholar]
  10. Ponfick VA. Ueber leberresection und leberreaction. Germany: Verhandl DeutschGessellsch Chir; 1890:19–28. [Google Scholar]
  11. Starzl TE, Porter KA, Francavilla JA. A hundred years of the hepatotrophic controversy. Ciba Found Symp. 1977:111–129. [Google Scholar]
  12. Fausto N, Webber EM. Liver regeneration. In: Arias M, Boyer JL, Fausto N, Jakoby WB, Schachter D, Shafritz DA, eds. The Liver Biology and Pathobiology. New York: Raven Press; 1994:1059–1084. [Google Scholar]
  13. Diehl AM, Rai R. Regulation of liver regeneration by pro-inflammatory cytokines. J Gastroenterol Hepatol. 1996;11:466–470. [CrossRef] [PubMed] [Google Scholar]
  14. Michalopoulos GK, DeFrances MC. Liver regeneration. Science. 1997;276:60–66. [CrossRef] [PubMed] [Google Scholar]
  15. Sen S, Williams R, Jalan R. The pathophysiological basis of acuteon-chronic liver failure. Liver. 2002;22(Suppl 2):5–13. [CrossRef] [PubMed] [Google Scholar]
  16. Jauregui HO, Mullon CJ-P, Solomon B. Extracorporeal artificial liver support. In: Lanza RP, Langer R, Chick WL, eds. Principles of Tissue Engineering. San Diego, CA: Academic Press & Austin, TX: Landes; 1997:568–612. [Google Scholar]
  17. Hoofnagle JH, Carithers RL, Shapiro C, Ascher N. Fulminant hepatic failure: Summary of a workshop. Hepatology. 1995;21:240–252. [PubMed] [Google Scholar]
  18. Carpentier B, Gautier A, Legallais C. Artificial and bioartificial liver devices: Present and future. Gut. 2009;58:1690–1702. [CrossRef] [PubMed] [Google Scholar]
  19. Powers KA, Ribeiro RM, Patel K, et al. Kinetics of hepatitis C virus reinfection after liver transplantation. Liver Transpl. 2006; 12:207–216. [CrossRef] [PubMed] [Google Scholar]
  20. Stickel F, Hoehn B, Schuppan D, Seitz HK. Review article: Nutritional therapy in alcoholic liver disease. Aliment Pharmacol Ther. 2003;18:357–373. [CrossRef] [Google Scholar]
  21. Hoofnagle J, Carithers R, Shapiro C, Ascher N. Fulminant hepatic failure, summary of a workshop. Hepatology. 1995;21:240–252. [PubMed] [Google Scholar]
  22. Bernuau J, Rueff B, Benhamou JP. Fulminant and subfulminant liver failure definitions and causes. Semin Liver Dis. 1996;6:97–106. [Google Scholar]
  23. Hughes RD, Nicolaou N, Langley PG, Ellis AJ, Wendon JA, Williams R. Plasma cytokine levels and coagulation and complement activation during use of the extracorporeal liver assist device in acute liver failure. Artif Organs. 1998;22:854–858. [CrossRef] [PubMed] [Google Scholar]
  24. Rave SD, Tilanus HW, Linden JVD, et al. The importance of orthotopic liver transplantation in acute hepatic failure. Transpl Int. 2002;15:29–33. [CrossRef] [PubMed] [Google Scholar]
  25. Bernuau J, Rueff B, Benhamou JP. Fulminant and subfulminant liver failure, definitions and causes. Semin Liver Dis. 1986;6:97–106. [CrossRef] [PubMed] [Google Scholar]
  26. Bernal W, Wendon J. Liver transplantation in adults with acute liver failure. J Hepatol. 2004;40:192–197. [CrossRef] [Google Scholar]
  27. Rivera PT, Moreno J, Skaff C, McDiarmid S, Vargas J, Ament ME. Delayed encephalopathy in fulminant hepatic failure in the pediatric population and the role of liver transplantation. J Pediatr Gastroenterol Nutr. 1997;24:128–134. [CrossRef] [PubMed] [Google Scholar]
  28. Pauwels A, Mostefa N, Florent C, Levy VG. Emergency liver transplantation for acute liver failure. J Hepatol. 1993;17:124–127. [CrossRef] [Google Scholar]
  29. PHS Guideline on Infectious Disease Issues in Xenotransplantation, Food and Drug Administration, January 19, 2001. Available at: http://www.fda.gov/biologicsbloodvaccines/guidancecomplianceregulatoryinformation/guidances/xenotransplantation/ucm074727.htm. Accessed December 29, 2011. [Google Scholar]
  30. Jalan R, Sen S, Williams R. Prospects for extracorporeal liver support. Gut. 2004;53:890–898. [CrossRef] [PubMed] [Google Scholar]
  31. Opolon P. High permeability membrane hemodialysis and hemofiltration in acute hepatic coma. Artif Organs. 1979;3:354–360. [Google Scholar]
  32. Knell AJ, Dukes DC. Dialysis procedures in acute liver failure. Lancet. 1976;2:402–403. [CrossRef] [Google Scholar]
  33. Denis J, Opolon P, Delmore M. Long-term extracorporeal assistance by continuous hemofiltration during fulminant hepatic failure. Gastroenterol Clin Biol. 1992;3:337–348. [Google Scholar]
  34. Gleissner M, Bornemann R, Stemerowicz R, Meissler M, Neuhaus P, Gerlach JC. Immunoisolation of hybrid liver support systems by semipermeable membranes. Int J Artif Organs. 1997;20:644–649. [CrossRef] [PubMed] [Google Scholar]
  35. Nyberg SL, Misra SP. Hepatocyte liver-assist systems—A clinical update. Mayo Clin Proc. 1998;73:765–771. [CrossRef] [Google Scholar]
  36. Ellis AJ, Hughes RD, Nicholl D. Temporary extracorporeal liver support for severe acute alcoholic hepatitis using the BioLogic-DT. Int J Artif Organs. 1999;22:27–34. [CrossRef] [PubMed] [Google Scholar]
  37. Arkadopoulos N, Detry O, Rozga J, Demetriou AA. Liver assist systems, state of the art. Int J Artif Organs. 1998;21:781–787. [CrossRef] [PubMed] [Google Scholar]
  38. Chari RS, Collins BH, Magee JC, et al. Treatment of hepatic failure with ex vivo pig-liver perfusion followed by liver transplantation. N Engl J Med. 1994;331:234–237. [CrossRef] [PubMed] [Google Scholar]
  39. Strain AJ, Neuberger JM. A bioartificial liver—State of the art. Science. 2002;295:1005–1009. [CrossRef] [PubMed] [Google Scholar]
  40. Detry O, Arkadopolulos N, Ting P. Clinical use of a bioartificial liver in the treatment of acetaminophen-induced fulminant hepatic failure. Am Surg. 1999;65:934–938. [CrossRef] [PubMed] [Google Scholar]
  41. Gerlach J. Development of a hybrid liver support system, a review. Int J Artif Organs. 1996;19:645–654. [CrossRef] [PubMed] [Google Scholar]
  42. Stange J, Mitzner S. Cell sources for bioartificial liver support. Int J Artif Organs. 1996;19:14–17. [CrossRef] [PubMed] [Google Scholar]
  43. Sielaff TD, Hu MY, Rao S, Groehler K. A technique for porcine hepatocyte harvest and description of differentiated metabolic functions in static culture. Transplantation. 1995;59:145–163. [Google Scholar]
  44. Nyberg SL, Payne WD, Amiot B, Shirabe K. Demonstration of biochemical function by extracorporeal xenohepatocytes in an hepatic animal model. Transplant Proc. 1993;25:1944–1945. [Google Scholar]
  45. Dixit V, Gitnick G. Artificial liver support, state of the art. Scand J Gastroenterol Suppl. 1995;220:1101–1114. [Google Scholar]
  46. Roberts EA, Letarte M, Squire J, Yang SY. Characterization of human hepatocyte lines derived from normal liver tissue. Hepatology. 1994;19:1390–1399. [CrossRef] [PubMed] [Google Scholar]
  47. Schumacher IK, Okamoto T, Kim BH, Chowdhury NR, Chowdhury JR, Fox IJ. Transplantation of conditionally immortalized hepatocytes to treat hepatic encephalopathy. Hepatology. 1996; 24:337–343. [CrossRef] [PubMed] [Google Scholar]
  48. Liu J, Pan J, Naik S, Santangini H, Trenkler D. Characterization and evaluation of detoxification functions of a nontumorigenic immortalized porcine hepatocyte cell line. Cell Transplant. 1999;8:219–232. [CrossRef] [PubMed] [Google Scholar]
  49. Jauregui HO, Chowdhury NR, Chowdhury JR. Use of mammalian cells for artificial liver support. Cell Transplant. 1996;5:353–367. [CrossRef] [PubMed] [Google Scholar]
  50. Sussman NL, Gislason GT, Conlin CA, Kelly JH. The hepatic extra-corporeal liver assist device, initial clinical experience. Artif Organs. 1994;18:390–396. [CrossRef] [PubMed] [Google Scholar]
  51. Landry J, Bernier D, Ouellet C, Goyette R. Spheroidal aggregate culture of rat liver cells, histotypic reorganization, biomatrix deposition, and maintenance of functional activities. J Cell Biol. 1985;101:914–923. [CrossRef] [PubMed] [Google Scholar]
  52. Jones EA, Tosh D, Wilson DI, Lindsay S, Forrester LM. Hepatic differentiation of murine embryonic stem cells. Exp Cell Res. 2002;272:15–22. [CrossRef] [Google Scholar]
  53. Court FG, Wemyss-Holden SA, Dennison AR, Maddern GJ. Bioartificial liver support devices, historical perspectives. ANZ J Surg. 2003;73:739–748. [CrossRef] [Google Scholar]
  54. Hu WS, Friend JR, Wu FJ, Sielaff T. Development of a bioartificial liver employing xenogeneic hepatocytes. Cytotechnology. 1997;23:29–38. [CrossRef] [PubMed] [Google Scholar]
  55. Gerlach JC, Schnoy N, Vienken J, Smith M, Neuhaus P. Comparison of hollow fibre membranes for hepatocyte immobilization in bioreactors. Int J Artif Organs. 1996;19:610–616. [CrossRef] [PubMed] [Google Scholar]
  56. Wu FJ, Friend JR, Lazar A, Mann HJ. Hollow fiber bioartificial liver utilizing collagen-entrapped porcine hepatocytes spheroids. Biotechnol Bioeng. 1996;52:34–44. [CrossRef] [PubMed] [Google Scholar]
  57. Giorgio TD, Moscioni AD, Rozga J, Demetriou AA. Mass transfer in a hollow fiber device used as a bioartificial liver. ASAIO J. 1993;39:886–892. [CrossRef] [PubMed] [Google Scholar]
  58. Qiang S, Yaoting Y, Hongyin L, Klinkmann H. Comparative evaluation of different membranes for the construction of an artificial liver support system. Int J Artif Organs. 1997;20:119–124. [CrossRef] [PubMed] [Google Scholar]
  59. Jozwiak A, Karlik W, Wiechetek M, Werynski A. Attachment and metabolic activity of hepatocytes cultivated on selected polymeric membranes. Int J Artif Organs. 1998;21:460–466. [CrossRef] [PubMed] [Google Scholar]
  60. Yanagi K, Miyoshi H, Fukuda H, Ohshima N. A packed-bed reactor utilizing porous resin enables high density culture of hepatocytes. Appl Microbiol Biotechnol. 1992;37:316–320. [CrossRef] [PubMed] [Google Scholar]
  61. Weston MJ, Mellon PJ, Langley PG. Resin column perfusion with whole blood or plasma separated by continuous flow centrifuge. Clin Sci Mol Med. 1975;48:187–192. [Google Scholar]
  62. Patzer JF, Mazariegos GV, Lopez R. Novel bioartificial liver support system-preclinical evaluation. Ann N Y Acad Sci. 1999;875:340–352. [CrossRef] [PubMed] [Google Scholar]
  63. Lozinsky V, Galaev IY, Plieva FM, Savina IN, Jungvid H, Mattiasson B. Polymeric cryogels as promising materials of biotechnological interest. Trends Biotechnol. 2003;21:445–451. [CrossRef] [Google Scholar]
  64. Lozinsky VI, Plieva FM, Galaev YI, Mattiasson B. The potential of polymeric cryogels in bioseparation. Bioseparation. 2006;10:163–188. [Google Scholar]
  65. Tripathi A, Kathuria N, Kumar A. Elastic and macroporous agarose–gelatin cryogels with isotropic and anisotropic porosity for tissue engineering. J Biomed Mater Res A. 2009;90A:680–694. [CrossRef] [Google Scholar]
  66. Kathuria N, Tripathi A, Kar KK, Kumar A. Synthesis and characterization of elastic and macroporous chitosan-gelatin cryogel for tissue engineering. Acta Biomater. 2009;5:406–418. [CrossRef] [Google Scholar]
  67. Kumar A, Plieva FM, Galaev IY, Mattiasson B. Affinity fractionation of lymphocytes using a monolithic cryogel. J Immunol Methods. 2003;283:185–194. [CrossRef] [PubMed] [Google Scholar]
  68. Lozinsky VI, Plieva FM. Poly(vinyl alcohol) cryogels employed as matrices for cell immobilization. III. Overview of recent research and developments. Enzyme Microb Technol. 1998;23:227–242. [CrossRef] [Google Scholar]
  69. Bloch K, Lozinsky VI, Galaev IY, et al. Functional activity of insulinoma cells (INS-1E) and pancreatic islets cultured in agarose cryogel sponges. J Biomed Mater Res A. 2005;75A:802–809. [CrossRef] [Google Scholar]
  70. Nilsang S, Nandakumar KS, Galaev IY, et al. Monoclonal antibody production using a new supermacroporous cryogel bioreactor. Biotechnol Prog. 2008;23:932–939. [Google Scholar]
  71. Xue YL, Zhao SF, Luo Y, et al. A hybrid artificial liver support system in treatment of acute liver failure. World J Gastroenterol. 2001;7:826–829. [CrossRef] [PubMed] [Google Scholar]
  72. Ding YT, Qiu YD, Chen Z, et al. The development of a new bioartificial liver and its application in 12 acute liver failure patients. World J Gastroenterol. 2003;9:829–832. [CrossRef] [PubMed] [Google Scholar]
  73. Donini A, Baccarani U, Risaliti A, Degrassi A. Temporary neurological improvement in a patient with acute or chronic liver failure treated with a bioartificial liver device. Am J Gastroenterol. 2002;95:1102–1104. [Google Scholar]
  74. Mizumoto H, Funatsu H. Liver regeneration using a hybrid artificial liver support system. Artif Organs. 2004;28:53–57. [CrossRef] [PubMed] [Google Scholar]
  75. Dixit V, Gitnick G. The bioartificial liver—State of the art. Eur J Surg. 1998;164:71–76. [Google Scholar]
  76. Bartolo D, Jarosch SL, Haverich G, Bader A. A novel full-scale flat membrane bioreactor utilizing porcine hepatocytes, cell viability and tissue-specific functions. Biotechnol Prog. 2000;16:102–108. [CrossRef] [PubMed] [Google Scholar]
  77. Watanabe FD, Mullon CJ, Hewitt WR, et al. Clinical experience with a bioartificial liver in the treatment of severe liver failure. A phase I clinical trial. Ann Surg. 1997;225:484–491. [CrossRef] [PubMed] [Google Scholar]
  78. Rozga J, Holzman MD, Ro MS, et al. Development of a hybrid bioartificial liver. Ann Surg. 1993;217:502–509. [CrossRef] [PubMed] [Google Scholar]
  79. Kobayashi N, Okitsu T, Nakaji S, Tanaka N. Hybrid bioartificial liver: establishing a reversibly immortalized human hepatocyte line and developing a bioartificial liver for practical use. J Artif Organs. 2003;6:236–244. [CrossRef] [PubMed] [Google Scholar]
  80. Ellis AJ, Hughes RD, Wendon JA, et al. Pilot-controlled trial of the extracorporeal liver assist device in acute liver failure. Hepatology. 1996;24:1446–1451. [CrossRef] [PubMed] [Google Scholar]
  81. Sauer IM, Zeilinger K, Obermayer N, et al. Primary human liver cells as source for modular extracorporeal liver support—A preliminary report. Int J Artif Organs. 2002;25:1001–1005. [CrossRef] [PubMed] [Google Scholar]
  82. Flendrig LM, La JW, Joming GG. In vitro evaluation of a novel bioreactor based on an integral oxygenator and a spirally wound non-woven polyester matrix for hepatocyte culture as small aggregates. J Hepatol. 1997;26:1379–1392. [CrossRef] [Google Scholar]

Current usage metrics show cumulative count of Article Views (full-text article views including HTML views, PDF and ePub downloads, according to the available data) and Abstracts Views on Vision4Press platform.

Data correspond to usage on the plateform after 2015. The current usage metrics is available 48-96 hours after online publication and is updated daily on week days.

Initial download of the metrics may take a while.